Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations

Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations

Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidity and mortality worldwide. Several TB vaccine candidates are currently in clinical and preclinical development. They fall into two categories, the one of candidates designed as a replacement of the Bacille Cal...

Full description

Bibliographic Details
Main Authors: Amaya Leunda, Aline Baldo, Martine Goossens, Kris Huygen, Philippe Herman, Marta Romano
Format: Article
Language:English
Published: MDPI AG 2014-06-01
Series:Vaccines
Subjects:
tuberculosis
vaccine candidate
clinical trial
genetically modified organism
risk assessment
biosafety
Online Access:http://www.mdpi.com/2076-393X/2/2/463

Internet

http://www.mdpi.com/2076-393X/2/2/463

Similar Items